Fixed-Dose Nivolumab Costs More Than Simulated Weight-Based Dosing in Japan
A study of 3,243 Japanese patients found that observed fixed-dose nivolumab billing was a median of 89,540 yen higher per ...
A study of 3,243 Japanese patients found that observed fixed-dose nivolumab billing was a median of 89,540 yen higher per ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.